In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Miragen Therapeutics Inc. (NASDAQ:MGEN) reported that Boulder Ventures V, L.p. has picked up 1,607,437 of common stock as of 2017-02-24.
The acquisition brings the aggregate amount owned by Boulder Ventures V, L.p. to a total of 1,607,437 representing a 7.5% stake in the company.
For those not familiar with the company, miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discovering and developing innovative microRNA-targeting therapies to improve human health.
A glance at Miragen Therapeutics Inc. (NASDAQ:MGEN)’s key stats reveals a current market capitalization of 297.99 Million based on 21.30million shares outstanding and a price at last close of $13.92 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-11-20, Riccitelli picked up 7,000 at a purchase price of $0.80. This brings their total holding to 345,130 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Miragen Therapeutics Inc. (NASDAQ:MGEN)
as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
